{"title":"RETRACTION: Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk.","authors":"","doi":"10.1002/1873-3468.15076","DOIUrl":null,"url":null,"abstract":"<p><strong>Retraction: </strong>A. Adhikary, S. Mohanty, L. Lahiry, D. S. Hossain, S. Chakraborty and T. Das, \"Theaflavins Retard Human Breast Cancer Cell Migration by Inhibiting NF-κB via p53-ROS Cross-talk,\" FEBS Letters 584, no. 1 (2010): 7-14, https://doi.org/10.1016/j.febslet.2009.10.081. The above article, published online on 31 October 2009 in Wiley Online Library (wileyonlinelibrary.com), has been published by agreement between the journal Editor-in-Chief, Michael Brunner; FEBS Press; and John Wiley and Sons Ltd. The retraction has been agreed due to partial duplication of micrographs observed in Figure 2C and the unexpected similarity of curves presented in 3C. Additionally, the blot against histone H1 in figure 4D (bottom-left panel) is a stretched duplication of the blot against alpha-actin in figure 3F (right-hand panel). Further, duplications have been observed between the MCF-7 p53 bands presented in Figures 1D and the p53 bands in Figure 3F; the alpha actin bands shown in Figure 3F and the Histone H1 bands in Figure 4D; and the alpha actin bands presented in Figures 3E and 4D. The authors provided some supporting data and an explanation, but the editors found them unsatisfactory. Due to the extent and nature of these concerns, the editors consider the results and conclusions of this article to be invalid. The authors disagree with the retraction.</p>","PeriodicalId":12142,"journal":{"name":"FEBS Letters","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FEBS Letters","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1002/1873-3468.15076","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
Abstract
Retraction: A. Adhikary, S. Mohanty, L. Lahiry, D. S. Hossain, S. Chakraborty and T. Das, "Theaflavins Retard Human Breast Cancer Cell Migration by Inhibiting NF-κB via p53-ROS Cross-talk," FEBS Letters 584, no. 1 (2010): 7-14, https://doi.org/10.1016/j.febslet.2009.10.081. The above article, published online on 31 October 2009 in Wiley Online Library (wileyonlinelibrary.com), has been published by agreement between the journal Editor-in-Chief, Michael Brunner; FEBS Press; and John Wiley and Sons Ltd. The retraction has been agreed due to partial duplication of micrographs observed in Figure 2C and the unexpected similarity of curves presented in 3C. Additionally, the blot against histone H1 in figure 4D (bottom-left panel) is a stretched duplication of the blot against alpha-actin in figure 3F (right-hand panel). Further, duplications have been observed between the MCF-7 p53 bands presented in Figures 1D and the p53 bands in Figure 3F; the alpha actin bands shown in Figure 3F and the Histone H1 bands in Figure 4D; and the alpha actin bands presented in Figures 3E and 4D. The authors provided some supporting data and an explanation, but the editors found them unsatisfactory. Due to the extent and nature of these concerns, the editors consider the results and conclusions of this article to be invalid. The authors disagree with the retraction.
引用本文:A. Adhikary, S. Mohanty, L. Lahiry, D. S. Hossain, S. Chakraborty, T. Das,“茶黄素抑制NF-κB和p53-ROS的相互作用对乳腺癌细胞迁移的影响”,《中华医学杂志》第584期。1 (2010): 7-14, https://doi.org/10.1016/j.febslet.2009.10.081。上述文章已于2009年10月31日在Wiley在线图书馆(wileyonlinelibrary.com)上发表,经该杂志总编辑Michael Brunner;2月出版社;及约翰威利父子有限公司。由于图2C中观察到的显微照片部分重复,以及3C中呈现的曲线的意外相似性,已同意撤回。此外,图4D(左下面板)中针对组蛋白H1的印迹是图3F(右下面板)中针对α -肌动蛋白的印迹的延伸复制。此外,图1D所示的MCF-7 p53条带与图3F所示的p53条带之间存在重复;图3F中的α肌动蛋白条带和图4D中的组蛋白H1条带;α肌动蛋白带如图3E和4D所示。作者提供了一些支持数据和解释,但编辑们感到不满意。由于这些问题的程度和性质,编辑认为本文的结果和结论无效。作者不同意撤稿。
期刊介绍:
FEBS Letters is one of the world''s leading journals in molecular biology and is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Minireviews, Research Letters and Hypotheses that merit urgent publication.